NCT06016660

Brief Summary

The aim of our study is to investigate the effects of single-session resistance exercise, neuromuscular electrical stimulation, and transcutaneous electrical stimulation on the level of muscle activation and their superiority over each other on both the ipsilateral and contralateral sides. Our randomized controlled crossover study included 21 participants (13 female, 8 male, age; 27.7±4). Transcutaneous electrical stimulation was used for sensory input. A single-session application was performed only to the right extremities of all participants, and the acute effects on muscle activation on both the ipsilateral and contralateral sides were evaluated. Muscle activation was evaluated with superficial EMG. SPSS® Statistics V22.0 software was used for statistical analysis. As a result of the statistical analysis, a significant increase in activation was found only in the sensory input application group on the ipsilateral side flexor carpi radialis (FCR) (p=0.001), flexor carpi ulnaris (FCU) (p\<0.001), flexor digitorum superficialis (FDS) (p=0.023) and flexor digitorum profundus (FDP) (p=0.003) muscles. On the contralateral side, there was an increase in activation in all muscles (FCR; p\<0.001, FCU; p=0.033, FDS; p=0.017 and FDP; p=0.001) in the resistant exercise group. In addition, there was a significant increase in the activation of certain muscles on the contralateral side in the NMES application group (FCR (p=0.049) and FDP (p=0.016) muscles) and the sensory input application group (FDP (p=0.004) and FDS (p=0.043) muscles). In situations where movement is contraindicated, ipsilateral sensory input can increase the level of muscle activation through both cortical and peripheral neural mechanisms.In addition, resistance exercise to be performed on the contralateral side can be an effective application to increase muscle activation on the ipsilateral side.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 7, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 30, 2023

Completed
Last Updated

August 30, 2023

Status Verified

August 1, 2023

Enrollment Period

5 months

First QC Date

June 7, 2023

Last Update Submit

August 27, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Superficial electromyography

    Muscle activation measurement

    through study completion, an average of 1 year

Study Arms (4)

Resistance exercise

EXPERIMENTAL

Resistance exercise

Other: Physiotherapy

Neuromuscular electrical stimulation

EXPERIMENTAL

Neuromuscular electrical stimulation

Other: Physiotherapy

Transcutaneous electrical stimulation

EXPERIMENTAL

Transcutaneous electrical stimulation

Other: Physiotherapy

Control

NO INTERVENTION

No intervention

Interventions

Resistance exercise, Neuromuscular electrical stimulation, and Transcutaneous electrical stimulation

Neuromuscular electrical stimulationResistance exerciseTranscutaneous electrical stimulation

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • After providing detailed information about the study, individuals who had agreed to participate in the research were included in the study.

You may not qualify if:

  • Individuals with any central or peripheral nervous system disease/injury affecting the upper extremity,
  • Individuals with a history of orthopedic injury that could impact the study,
  • Individuals with a history of neuromuscular disease, congenital anomalies, skin infections, or cognitive impairments,
  • Individuals with a history of systemic or metabolic diseases that could potentially affect the study,
  • Individuals with a body mass index (BMI) above 30 kg/m2.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Barış SEVEN

Izmir, Çiğli, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Motor Activity

Interventions

Physical Therapy Modalities

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ph.D. research assistant

Study Record Dates

First Submitted

June 7, 2023

First Posted

August 30, 2023

Study Start

May 1, 2022

Primary Completion

October 1, 2022

Study Completion

January 1, 2023

Last Updated

August 30, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations